Skip to content
Plate 06 · Procedures

Fat transfer: a separate operation with a separate risk profile

Fat transfer explained as a distinct operation: harvest, processing and grafting, why volume retention is unpredictable, recovery and the risk register.

Published by Northbank Media· Last reviewed 2026-08-01·Not medical advice
In short

Fat transfer takes fat removed by liposuction, processes it, and injects it into another part of the body to add volume. It is a second operation rather than an extension of the first, it carries risks that liposuction alone does not, and the proportion of grafted fat that survives is unpredictable in any individual, which is why a repeat procedure is often anticipated from the outset.

Plate 06. Surgical atlas study, procedures.

Why it is two operations, not one

The phrase used in marketing is usually some version of moving fat from where you do not want it to where you do. It is an appealing sentence and it obscures the clinical reality, which is that fat transfer combines two distinct surgical events in one session.

The first is a liposuction, with all of its risks and its own recovery at the donor site. The second is a grafting procedure at a completely different part of the body, with a different risk profile, different restrictions and a different timeline. Adding them together does not average the risk. It combines it.

That is why an operation described as a bonus on top of a liposuction should raise your guard. It is not a bonus. It is a second surgical field, more theatre time, more anaesthetic and a set of complications that liposuction alone cannot produce.

Harvest, processing and grafting

Fat intended for grafting is harvested more gently than fat intended for disposal, usually with finer cannulas and lower suction, because the cells have to survive. The aspirate is then processed to separate usable fat from fluid, blood and infiltration solution. Methods vary: decanting, filtration and centrifugation are all used, and surgeons hold different views about which is best.

The prepared fat is then injected into the recipient site, and this is where technique matters most. Grafted fat has no blood supply of its own. It survives only if it is close enough to living tissue for new vessels to grow into it. That means the fat has to be laid down in many fine passes, in small amounts, spread through the recipient tissue rather than deposited as a mass.

A large bolus of fat in one place has a centre that no blood supply can reach. That centre dies, and dead fat becomes a firm lump, an oil cyst or an area of calcification. This single physical constraint explains most of what is distinctive about the operation.

The retention problem

Not all grafted fat survives, and the proportion that does varies between people, between sites and between operations. Anyone quoting you a precise survival percentage should be asked where the figure comes from, what it was measured on and whether it applies to your recipient site.

Two practical consequences follow. The first is that the result immediately after surgery is not the result. Early volume includes swelling and infiltration fluid, and it will reduce. Judging the outcome before several months have passed is judging swelling.

The second is that a repeat session is frequently part of the plan rather than a sign that something went wrong. If a surgeon presents fat transfer as a single definitive operation with a guaranteed volume, they are describing something the biology does not support. A plan that anticipates a possible second session, and prices it transparently, is a more realistic one.

The risk that separates grafting from liposuction

Fat embolism is the complication that makes fat grafting categorically different from liposuction alone. If fat is introduced into a damaged vein under pressure, it can travel to the lungs and the heart. The consequences can be immediate and can be fatal.

The magnitude of this risk depends heavily on where the fat is being placed and how. Areas rich in large veins carry more risk than areas that are not, and injection into or beneath muscle carries more risk than injection into the fat layer. This is the reason the safety guidance around gluteal fat grafting specifically is different from the guidance around grafting elsewhere, and why we treat it as a separate page: gluteal fat grafting.

What you should expect in a consultation is that the embolic risk of your specific recipient site is named, explained and quantified only in terms of what is and is not known. Both the British Association of Aesthetic Plastic Surgeons and BAPRAS have published safety positions on this area, and a surgeon should be able to tell you where their practice sits relative to them.

The donor site is not free

It is easy to think of the donor site as a bonus: you were having that area reduced anyway. In practice the donor site has its own considerations.

Fat harvested for grafting is taken more gently and often from a wider area, because the priority is cell survival rather than contour. That can mean the donor site result is less refined than it would have been if contour had been the only goal. And where a large graft volume is needed, there is pressure to harvest aggressively, which is precisely how donor site irregularity and over-resection occur.

If you have limited fat to give, that is a genuine constraint on what can be achieved, and a surgeon who tells you so is being accurate rather than unhelpful.

Restrictions people underestimate

Recipient site restrictions are the part of fat transfer recovery that most surprises people. Grafted fat needs to be left undisturbed while it establishes a blood supply, which means pressure on the area is restricted, sometimes severely and sometimes for weeks. Depending on the site, that can affect how you sit, how you sleep, how you travel and whether you can work at all.

These restrictions are not precautionary flourishes. Pressure on a fresh graft reduces survival and can cause fat necrosis. If the restrictions are incompatible with your circumstances for the required period, that is a reason to delay or decline, not a reason to negotiate them down.

What to ask

  • How much fat do I have available, and is it enough for what we are discussing?
  • What proportion do you expect to retain, and what is that based on?
  • Do you anticipate a second session, and what would that cost?
  • What plane are you injecting into, and why that one?
  • What is the embolic risk at this specific site, and what do you do to reduce it?
  • What exactly can I not do afterwards, and for how long?

The answers to these questions describe an operation. If a consultation instead produces reassurance about how natural the result will be, you have been sold a concept rather than given a plan.

Procedure recordFat transfer
Operation
Liposuction harvest, processing of the aspirate, and injection of prepared fat into a recipient site
What is changed
Volume and shape at the recipient site, plus the usual liposuction change at the donor site
What is not changed
The certainty of the outcome. A variable and unpredictable proportion of grafted fat does not survive.
Setting
A registered surgical facility. Two surgical fields are involved, which raises the requirement rather than lowering it.
Anaesthesia
Sedation or general anaesthetic in most cases, given that two sites are treated
Theatre time
Longer than harvest alone because processing and grafting are separate stages. Commonly described in ranges of two to four hours.
Stay
Day case or overnight depending on the sites, volume and anaesthetic
Incisions
Access points at both the donor and recipient sites
Result readable
Long. Early volume includes fluid and swelling that will not persist. Settled volume is a matter of many months.
Reversible
Partially and unpredictably. Grafted fat can be reduced by further liposuction but the result of that is uncertain.
Recovery, staged, with restrictions
Stage 1First week
  • Two recovering sites, each with its own instructions
  • Pressure on the recipient site is usually restricted, sometimes including sitting or lying positions
  • Analgesia and movement as instructed
Stage 2Week 2 to 6
  • Donor site compression continues
  • Recipient site restrictions continue and are often the harder part
  • Swelling at the recipient site makes volume look greater than it will be
Stage 3Month 2 to 4
  • Graft volume reduces as unsurvived fat is reabsorbed
  • The true volume becomes apparent
  • Firm areas or lumps at the recipient site should be reported rather than waited out
Stage 4Month 4 to 12
  • Settled volume
  • Assessment of whether a further session is wanted
  • Donor site contour becomes readable
Risk register
Graft-specific
Unpredictable volume retentionFat necrosis producing firm lumpsOil cysts and calcification within the grafted areaAsymmetry as the two sides retain differentlyInfection within the graft
Embolic
Fat embolism, which is the serious risk that distinguishes grafting from liposuction alone, and which varies substantially with the recipient site and the technique used
Donor site
All the ordinary liposuction risks at the harvest areaContour irregularity at the donor siteOver-harvest to obtain volume
Anaesthetic
Complications of sedation or general anaesthesiaLocal anaesthetic systemic toxicity from infiltration
Clotting
Deep vein thrombosisPulmonary embolism
Wound and infection
Infection at either siteDelayed healingScarring at access points
Outcome
Insufficient volume retainedThe need for a repeat session, with its own risksA shape that changes as the graft settles
No probability is attached to any entry above, and none should be. Probability depends on you, on the operation, on the setting and on the surgeon. Reliable, comparable, published complication rates for cosmetic surgery in the United Kingdom largely do not exist, because outcome reporting across the independent sector is not mandatory and the denominators are unknown. Any figure quoted to you without a source and a denominator should be treated as marketing.
Reasons not to have this operationThis panel appears on every procedure page. Any one of these is a sufficient reason to stop, and stopping is a legitimate outcome of a good consultation rather than a failure of one.
  1. You have been told the fat is being moved rather than that a second operation is being performed. Those are different descriptions of the same event and only one of them is accurate.
  2. Nobody has told you what proportion of the graft is expected to survive, or has quoted a precise figure without a source. Retention is genuinely unpredictable in an individual.
  3. You do not have enough donor fat and the plan involves harvesting aggressively to find it. Over-harvest creates a donor site problem in exchange for a recipient site gain.
  4. The recipient site restrictions are incompatible with your life for the required period. For some sites those restrictions are severe and unavoidable.
  5. You are expecting one operation. Repeat sessions are commonly anticipated and should be discussed as part of the plan and the price from the beginning.
  6. The specific embolic risk of your recipient site has not been named and explained.
No commercial links on this page

This article contains no affiliate links, no sponsored placement and no link to any clinic, hospital, surgeon, brand or commercial provider. Nobody paid for it, nobody previewed it and nobody outside the editorial team saw it before publication.

We name no surgeon, clinic or hospital anywhere in editorial, and we operate no lead generation into surgical procedures. Our commercial model is published in full, including the list of what we refuse at any price, at commercial terms.

Nothing here is medical advice, and nothing here is intended to encourage an operation. Speak to a doctor who has examined you, and to your GP.

Sources

Institution level references only: regulators, royal colleges, professional associations, NICE, the NHS and peer-reviewed literature. We do not cite commercial sources for clinical claims. External links open on those bodies' own sites.

  • British Association of Aesthetic Plastic SurgeonsUK association publishing safety positions on aesthetic surgical practice, including fat grafting. baaps.org.uk
  • British Association of Plastic, Reconstructive and Aesthetic SurgeonsProfessional association for plastic surgery in the UK, with patient information on procedures. www.bapras.org.uk
  • NHS: cosmetic proceduresPatient-facing guidance on cosmetic procedures and how to consider them. www.nhs.uk
  • General Medical Council: cosmetic interventions guidanceProfessional standards for doctors carrying out cosmetic procedures. www.gmc-uk.org

Frequently asked questions

Is fat transfer part of a liposuction?

No. It is a second operation performed in the same session, at a different site, with its own risks, restrictions and recovery. Combining them adds risk rather than averaging it.

How much of the grafted fat survives?

It varies between people, sites and operations, and no single figure applies to everyone. Ask any surgeon quoting a percentage where it comes from and whether it applies to your recipient site.

Why might I need a second session?

Because a variable proportion of grafted fat is reabsorbed. A plan that anticipates a possible second session is more realistic than one that promises a definitive result from one operation.

What is fat necrosis?

It is grafted fat that has died because no blood supply reached it, typically where too much was placed in one spot. It presents as a firm lump and can form an oil cyst or calcify.

Is fat transfer safer than an implant?

It is a different set of risks, not a smaller one. It avoids implant-specific problems and introduces graft-specific ones, including fat necrosis and, at some sites, fat embolism.

Can grafted fat be removed if I do not like it?

Partially, by further liposuction, with an uncertain result. Plan on the basis that reversal is imperfect.

Continue

Follow the record

We email when a procedure record is revised or when UK regulatory guidance changes in a way that affects what is published here.

Infrequent. No promotions, no clinic marketing and no provider content. One labelled sponsor block per issue, described in full at commercial terms. Sponsors receive no subscriber data and have no editorial influence.